FDA Adverse Event Malfunction Summary report: N

OCS HEART SYSTEM

MDR report key: 20114899 · Received August 31, 2024

Report

Report Number
3003152463-2024-00009
Event Type
Malfunction
Date Received
August 31, 2024
Date of Event
October 22, 2023
Report Date
August 31, 2024
Manufacturer
TRANSMEDICS INC.
Product Code
QIK
PMA / PMN Number
P200031
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
UK
Reporter Occupation
OTHER

Narratives

Description of Event or Problem · 0

THIS EVENT IS BEING REPORTED TO THE FDA AS A PART OF PROACTIVE QUALITY PLAN UNDERTAKEN BY TRANSMEDICS INC. THE REPORTABLE MALFUNCTIONS UNDER THIS QUALITY PLAN REPRESENT <(B)(4) % OF ALL OCS TRANSPLANTS. DURING THE RETURN FROM PROCURING A DCD HEART, THE SYSTEM WAS UNABLE TO ACHIEVE PERFUSATE TEMPERATURES GREATER THAN THE HIGH 20S C. HEART FIBRILLATION WAS OBSERVED AND THE DONOR ORGAN WAS DECLINED DUE TO THE MALFUNCTION. THE HEART PERFUSION MODULE (HPM) WAS DISPOSED AT THE DONOR HOSPITAL AND WAS NOT RETURNED TO TRANSMEDICS. BASED ON THE AVAILABLE INFORMATION, THE REPORTED CONDITION THAT THE SYSTEM WOULDN'T HEAT THE PERFUSATE WAS CONFIRMED. TRANSMEDICS ANALYZED THE SESSION FILES AND IDENTIFIED THAT CONSOLE WAS UNABLE TO READ THE EEPROM FROM THE PERFUSION MODULE. IF THE EEPROM CANNOT BE READ, THE CONSOLE WILL NOT SEND POWER TO THE HEATERS TO WARM THEPERFUSATE. HOWEVER, THE CAUSE OF THE ERROR COULD NOT BE DETERMINED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1079415 OCS HEART SYSTEM OCS HEART QIK TRANSMEDICS INC.

Patients

Seq Age Sex Outcome Treatment
1 NA Prefer Not To Disclose